Dear Deeply Readers,

Welcome to the archives of Syria Deeply. While we paused regular publication of the site on May 15, 2018, and transitioned some of our coverage to Peacebuilding Deeply, we are happy to serve as an ongoing public resource on the Syrian conflict. We hope you’ll enjoy the reporting and analysis that was produced by our dedicated community of editors contributors.

We continue to produce events and special projects while we explore where the on-site journalism goes next. If you’d like to reach us with feedback or ideas for collaboration you can do so at partners@newsdeeply.com.

MSF Dispatch: Thousands in Damascus Suffer Neurotoxic Symptoms

The following post is courtesy of Doctors Without Borders (MSF).

Written by MSF Staff Published on Read time Approx. 2 minutes

Three hospitals in Syria’s Damascus governorate that are supported by the international medical humanitarian organization Doctors Without Borders (Médecins Sans Frontières / MSF) reported that they received approximately 3,600 patients displaying neurotoxic symptoms in less than three hours on the morning of Wednesday, August 21.Of those patients, 355 reportedly died.

Since 2012, MSF has built a strong and reliable collaboration with medical networks, hospitals and medical points in the Damascus governorate, and has been providing them with drugs, medical equipment and technical support. Due to significant security risks, MSF staff members have not been able to access the facilities.

“Medical staff working in these facilities provided detailed information to MSF doctors regarding large numbers of patients arriving with symptoms including convulsions, excess saliva, pinpoint pupils, blurred vision and respiratory distress,” said Dr. Bart Janssens, MSF director of operations.

Patients were treated using MSF-supplied atropine, a drug used to treat neurotoxic symptoms. MSF is now trying to replenish the facilities’ empty stocks and provide additional medical supplies and guidance.

MSF can neither scientifically confirm the cause of these symptoms nor establish who is responsible for the attack,” said Dr. Janssens. “However, the reported symptoms of the patients, in addition to the epidemiological pattern of the events—characterized by the massive influx of patients in a short period of time, the origin of the patients, and the contamination of medical and first aid workers—strongly indicate mass exposure to a neurotoxic agent. This would constitute a violation of international humanitarian law, which absolutely prohibits the use of chemical and biological weapons.”

In addition to 1,600 vials of atropine supplied over recent months, MSF has now dispatched 7,000 additional vials to facilities in the area. Treatment of neurotoxic patients is now being fully integrated into MSF’s medical strategies in all its programs in Syria.

MSF hopes that independent investigators will be given immediate access to shed light on what happened,” said Christopher Stokes, MSF general director. “This latest attack and subsequent massive medical need come on top of an already catastrophic humanitarian situation, characterised by extreme violence, displacement, and deliberate destruction of medical facilities. In the case of such extreme violations of humanitarian law, humanitarian assistance cannot respond effectively and becomes meaningless itself.”

MSF provides medical assistance in Syria through two different approaches. MSF international and national staff operate six hospitals and four health centers in structures fully under the organization’s direct control in the north of Syria. In areas where MSF cannot send its own teams because of insecurity or lack of access, the organization has expanded a program begun two years ago of supporting Syrian medical networks, hospitals and medical posts, by providing drugs, medical equipment, and technical advice and support. Through the latter program, MSF has been supporting 27 hospitals and 56 medical posts throughout Syria.

From June 2012 through the end of June 2013, MSF teams carried out more than 55,000 medical consultations, 2,800 surgical procedures, and assisted in 1,000 births inside Syria. MSF teams have also provided more than 140,000 consultations for Syrian refugees in neighboring countries.

Suggest your story or issue.

Send

Share Your Story.

Have a story idea? Interested in adding your voice to our growing community?

Learn more